LKLukas C. KühN

Lukas C. KühN

*This is an algorithmically generated author record based on publicly available information.

Lukas C. KühN has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Larry Richman

    Swiss Institute for Experimental Cancer Research (ISREC), Genetics Unit, CH-1066 Epalinges, Switzerland

    2 shared publications
  • Afzal Muhammad Dogar

    Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zürich, CH-8093 Zürich, Switzerland

    1 shared publication
  • Anna Penelova

    Genetics Unit, Swiss Institute for Experimental Cancer Research (ISREC), Epalinges, Switzerland

    1 shared publication
  • Barbara Grisoni-Neupert

    Swiss Institute for Experimental Cancer Research (ISREC), Genetics Unit, CH-1066 Epalinges, Switzerland

    1 shared publication
  • Barbara Neupert

    Genetics Unit, Swiss Institute for Experimental Cancer Research (ISREC), Epalinges, Switzerland

    1 shared publication
  • Catherine Kuntz

    Swiss Institute for Experimental Cancer Research (ISREC), Genetics Unit, CH-1066 Epalinges, Switzerland

    1 shared publication

Latest Publications

  • Destabilization of Interleukin-6 mRNA Requires a Putative RNA Stem-Loop Structure, an AU-Rich Element, and the RNA-Binding Protein AUF1

    by Serge Paschoud, Afzal M. Dogar, Catherine Kuntz, Barbara Grisoni-Neupert, Larry Richman, Lukas C. KühN

    Interleukin-6 mRNA is unstable and degraded with a half-life of 30 min. Instability determinants can entirely be attributed to the 3′ untranslated region. By grafting segments of this region to stable green fluorescent protein mRNA and subsequent scanning mutagenesis, we have identified two conserved elements, which together account for most of the instability. The first corresponds to a short noncanonical AU-rich element. The other, 80 nucleotides further 5′, comprises a sequence predicted to form a stem-loop structure. Neither element alone was sufficient to confer full instability, suggesting that they might cooperate. Overexpression of myc-tagged AUF1 p37 and p42 isoforms as well as suppression of endogenous AUF1 by RNA interference stabilized interleukin-6 mRNA. Both effects required the AU-rich instability element. Similarly, the proteasome inhibitor MG132 stabilized interleukin-6 mRNA probably through an increase of AUF1 levels. The mRNA coimmunoprecipitated specifically with myc-tagged AUF1 p37 and p42 in cell extracts but only when the AU-rich instability element was present. These results indicate that AUF1 binds to the AU-rich element in vivo and promotes IL-6 mRNA degradation.


  • Analysis of the contribution of changes in mRNA stability to the changes in steady‐state levels of cyclin mRNA in the mammalian cell cycle

    by Anna Penelova, Larry Richman, Barbara Neupert, Viesturs Simanis, Lukas C. Kühn

    Cyclins are the essential regulatory subunits of cyclin‐dependent protein kinases. They accumulate and disappear periodically at specific phases of the cell cycle. Here we investigated whether variations in cyclin mRNA levels in exponentially growing cells can be attributed to changes in mRNA stability. Mouse EL4 lymphoma cells and 3T3 fibroblasts were synchronized by elutriation or cell sorting. Steady‐state levels and degradation of cyclin mRNAs and some other cell cycle related mRNAs were measured at early G 1 , late G 1 , S and G 2 /M phases. In both cell lines mRNAs of cyclins C, D1 and D3 remained unchanged throughout the cell cycle. In contrast, cyclin A2 and B1 mRNAs accumulated 3.1‐ and 5.7‐fold between early G 1 and G 2 /M phase, whereas cyclin E1 mRNA decreased 1.7‐fold. Mouse cyclin A2 and B1 genes, by alternative polyadenylation, gave rise to more than one transcript. In both cases, the longer transcripts were the minor species but accumulated more strongly in G 2 /M phase. All mRNAs were rather stable with half‐lives of 1.5–2 h for cyclin E1 mRNA and 3–4 h for the others. Changes in mRNA stability accounted for the accumulation in G 2 /M phase of the short cyclin A2 and B1 mRNAs, but contributed only partially to changes in levels of the other mRNAs.